Role of C3, C5 and Anaphylatoxin Receptors in Acute Lung Injury and in Sepsis

被引:131
作者
Bosmann, Markus [1 ]
Ward, Peter A. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
来源
CURRENT TOPICS IN INNATE IMMUNITY II | 2012年 / 946卷
基金
美国国家卫生研究院;
关键词
Complement; Anaphylatoxins; Immune complexes; Endotoxin; Sepsis; Septic shock; RESPIRATORY-DISTRESS SYNDROME; EXPERIMENTAL ALLERGIC-ASTHMA; MIGRATION-INHIBITORY FACTOR; COMPLEMENT IN-VIVO; INNATE IMMUNITY; REGULATORY ROLE; DEFICIENT MICE; ACTIVATION; PROTEIN; NEUTROPHILS;
D O I
10.1007/978-1-4614-0106-3_9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The complement system plays a major role in innate immune defenses against infectious agents, but exaggerated activation of complement can lead to severe tissue injury. Systemic (intravascular) activation of complement can, via C5a, lead to neutrophil (PMN) activation, sequestration and adhesion to the pulmonary capillary endothelium, resulting in damage and necrosis of vascular endothelial cells and acute lung injury (ALI). Intrapulmonary (intraalveolar) activation of complement can cause ALI that is complement and PMN-dependent, resulting in a cytokine/chemokine storm that leads to intense ALI. Surprisingly, C3(-/-) mice develop the full intensity of ALI in a C5a-dependent manner due to the action of thrombin that generates C5a directly from C5. There is conflicting evidence on the role of the second C5a receptor, C5L2 in development of ALI. There is accumulating evidence that C5a may suppress inflammatory responses or divert them from Th1 to Th2 responses, impacting the innate immune system. Finally, in experimental polymicrobial sepsis, there is evidence that many of the adverse outcomes can be linked to the roles of C5a and engagement of its two receptors, C5aR and C5L2. These observations underscore the diversity of effects of C5a in a variety of inflammatory settings.
引用
收藏
页码:147 / 159
页数:13
相关论文
共 58 条
[21]   The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein [J].
Kalant, D ;
Cain, SA ;
Maslowska, M ;
Sniderman, AD ;
Cianflone, K ;
Monk, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) :11123-11129
[22]   Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma [J].
Karp, CL ;
Grupe, A ;
Schadt, E ;
Ewart, SL ;
Keane-Moore, M ;
Cuomo, PJ ;
Köhl, J ;
Wahl, L ;
Kuperman, D ;
Germer, S ;
Aud, D ;
Peltz, G ;
Wills-Karp, M .
NATURE IMMUNOLOGY, 2000, 1 (03) :221-226
[23]   A regulatory role for the C5a anaphylatoxin in, type 2 immunity in asthma [J].
Köhl, J ;
Baelder, R ;
Lewkowich, IP ;
Pandey, MK ;
Hawlisch, H ;
Wang, LH ;
Best, J ;
Herman, NS ;
Sproles, AA ;
Zwirner, J ;
Whitsett, JA ;
Gerard, C ;
Sfyroera, G ;
Lambris, JD ;
Wills-Karp, M .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) :783-796
[24]   Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma [J].
Lajoie, Stephane ;
Lewkowich, Ian P. ;
Suzuki, Yusuke ;
Clark, Jennifer R. ;
Sproles, Alyssa A. ;
Dienger, Krista ;
Budelsky, Alison L. ;
Wills-Karp, Marsha .
NATURE IMMUNOLOGY, 2010, 11 (10) :928-U79
[25]  
LARSEN GL, 1981, AM REV RESPIR DIS, V123, P434
[26]   Anti-C5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis [J].
Laudes, IJ ;
Chu, JC ;
Sikranth, S ;
Huber-Lang, M ;
Guo, RF ;
Riedemann, N ;
Sarma, JV ;
Schmaier, AH ;
Ward, PA .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (05) :1867-1875
[27]   Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2 [J].
Lee, Hyun ;
Whitfeld, Peter L. ;
Mackay, Charles R. .
IMMUNOLOGY AND CELL BIOLOGY, 2008, 86 (02) :153-160
[28]   Complement component C5a is integral to the febrile response of mice to lipopolysaccharide [J].
Li, S ;
Boackle, SA ;
Holers, VM ;
Lambris, JD ;
Blatteis, CM .
NEUROIMMUNOMODULATION, 2005, 12 (02) :67-80
[29]   High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal [J].
Lotze, MT ;
Tracey, KJ .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (04) :331-342
[30]   Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation [J].
Makita, H ;
Nishimura, M ;
Miyamoto, K ;
Nakano, T ;
Tanino, Y ;
Hirokawa, J ;
Nishihira, J ;
Kawakami, Y .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (02) :573-579